Terveystalo Oyj header image

Terveystalo Oyj

TTALO

Equity

ISIN FI4000252127 / Valor 37893402

NASDAQ Helsinki Ltd, Equities (2024-09-18)
EUR 9.59-0.83%

Terveystalo Oyj
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Terveystalo Oyj stands as Finland's premier private healthcare service provider, distinguished by its extensive revenue and expansive network. It holds a significant position in the Nordic region as a foremost provider of occupational health services. The company's comprehensive offerings encompass a broad spectrum of primary healthcare, specialized care, and well-being services catering to a diverse clientele that includes corporate entities, private individuals, and the public sector. Terveystalo's innovative approach is further exemplified by its round-the-clock digital services, ensuring healthcare accessibility irrespective of geographical and temporal constraints. With a robust presence manifested through over 377 clinics across Finland and 152 occupational health service clinics in Sweden, Terveystalo demonstrates a commitment to healthcare excellence. The company's notable market position is underscored by its listing on the Helsinki Stock Exchange and its recognition as an attractive employer within the healthcare and pharmaceutical industry. In 2023, Terveystalo reported a revenue of EUR 1,286 million, serving approximately 1.2 million individual customers in Finland through around 7.6 million customer appointments. The organization's workforce comprises over 15,500 healthcare and well-being professionals, highlighting its substantial contribution to the healthcare sector. Additionally, Terveystalo's engagement in clinical research, through its Terveystalo Biobank and Clinical Research (TBCR) unit, emphasizes its role in advancing medical knowledge and practices.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Growth

Terveystalo Oyj reported a revenue increase of 2.7 percent year-on-year for the first quarter of 2024, reaching EUR 350.2 million compared to EUR 341.1 million in the same period the previous year. This growth was achieved despite having one less working day in the quarter.

Healthcare Services Segment

The Healthcare Services segment of Terveystalo Oyj saw a significant revenue increase of 7.3 percent, amounting to EUR 268.0 million in Q1 2024, up from EUR 249.8 million in Q1 2023. This growth was driven by a more favorable customer and service mix and successful commercial measures.

Adjusted EBITA

Adjusted earnings before interest, taxes, amortization, and impairment losses (EBITA) for Terveystalo Oyj increased by 29.5 percent year-on-year, reaching EUR 47.2 million in Q1 2024, up from EUR 36.5 million in Q1 2023. This improvement represents 13.5 percent of the revenue, driven by improved operational efficiency and better sales mix.

Earnings Per Share

Terveystalo Oyj's earnings per share (EPS) more than doubled in the first quarter of 2024, reaching EUR 0.19 compared to EUR 0.09 in the same period the previous year. This significant increase reflects the company's strong financial performance during the quarter.

Profit Improvement Program

Terveystalo Oyj launched a profit improvement program in Sweden during the fourth quarter of 2023, which progressed as planned in Q1 2024. The program aims to achieve a structural improvement in profitability, with the full impact expected to be realized by 2025.

Summarized from source with an LLMView Source

Key figures

23.6%1Y
-13.3%3Y
6.08%5Y

Performance

27.5%1Y
27.2%3Y
27.8%5Y

Volatility

Market cap

1357 M

Market cap (USD)

Daily traded volume (Shares)

27,582

Daily traded volume (Shares)

1 day high/low

9.67 / 9.52

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Essity AB
Essity AB Essity AB Valor: 36846754
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%SEK 315.50
Medicover AB
Medicover AB Medicover AB Valor: 36765439
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%SEK 193.40
Arjo AB
Arjo AB Arjo AB Valor: 39115843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.65%SEK 43.58
Biogaia AB
Biogaia AB Biogaia AB Valor: 118922125
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.37%SEK 115.00
Xvivo Perfusion AB
Xvivo Perfusion AB Xvivo Perfusion AB Valor: 19661174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.15%SEK 492.00
Calliditas Therapeutics AB
Calliditas Therapeutics AB Calliditas Therapeutics AB Valor: 42290712
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%SEK 206.20
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 59.23
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.65%EUR 45.26
MedNation AG
MedNation AG MedNation AG Valor: 331107
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.46
Nelnet Inc
Nelnet Inc Nelnet Inc Valor: 1665235
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.52%USD 113.28